ICOS and colitis: Additionally, the oral administration of these particular strains is able to reduce disease severity in mouse models of colitis and allergic diarrhea [33], possibly through a bacteria-induced upregulation of ICOS and a consequent increased production of regulatory T-cells that reduce exacerbated immune responses and inflammation.